Internal Medicine, Pulmonary Disease · Pottstown, PA
NPI
1609848456
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
1591 Medical Dr
Pottstown, PA, 19464
Phone (610) 326-8005
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.9M
80,399 services
Medicare patients, 2024
1,185
Average age 74
Drug cost, 2024
$3.7M
4,661 prescriptions
Company payments, 2025
$6,587
From 31 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by An H Pham was code J2182 (injection, mepolizumab, 1 mg), 26,216 times for 27 patients. In total An H Pham billed 80,399 services in 35 codes, and Medicare paid $1.9M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-12-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2182 Injection, mepolizumab, 1 mg | Office | 26,216 | 27 | $23.73 | $622K |
| J2356 Injection, tezepelumab-ekko, 1 mg | Office | 20,792 | 12 | $14.20 | $295K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 13,573 | 112 | $0.10 | $1,360 |
| J0517 Injection, benralizumab, 1 mg | Office | 1,807 | 15 | $130.54 | $236K |
| 99213 Office E&M - Established | Office | 1,637 | 836 | $67.35 | $110K |
| 96372 Injection Administration | Office | 1,200 | 178 | $11.44 | $14K |
| 94010 Pulmonary Function Testing | Office | 682 | 485 | $21.37 | $15K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 652 | 209 | $48.29 | $31K |
| 99214 Office E&M - Established | Office | 628 | 358 | $96.85 | $61K |
| 94729 Pulmonary Function Testing | Office | 465 | 408 | $44.64 | $21K |
| 94727 Pulmonary Function Testing | Office | 463 | 406 | $34.53 | $16K |
| 99204 Office E&M - New | Office | 173 | 173 | $124.54 | $22K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 156 | 141 | $13.28 | $2,072 |
| 95811 Sleep Study | Office | 124 | 124 | $516.50 | $64K |
| G0008 Administration of influenza virus vaccine | Office | 100 | 99 | $29.83 | $2,983 |
By year: 2022 $1.2M for 32,841 services; 2023 $1.4M for 43,029 services; 2024 $1.9M for 80,399 services.
Medicare prescription drug claims, 2024
In 2024, the drug An H Pham prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 856 prescriptions and refills. In total An H Pham wrote 4,661 Medicare prescriptions that cost $3.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 856 | 1,061 | 175 | $665K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 443 | 484 | 164 | $12K |
| Montelukast Sodium Generic | 369 | 759 | 103 | $4,725 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 323 | 398 | 87 | $244K |
| Prednisone Generic | 214 | 216 | 131 | $972 |
| Zolpidem Tartrate Generic | 160 | 210 | 58 | $644 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 150 | 207 | 43 | $19K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 142 | 168 | 25 | $76K |
| Breo Ellipta Fluticasone/Vilanterol | 138 | 198 | 26 | $75K |
| Theophylline Er Theophylline Anhydrous | 115 | 196 | 25 | $13K |
| Symbicort Budesonide/Formoterol Fumarate | 112 | 144 | 26 | $32K |
| Spiriva Respimat Tiotropium Bromide | 109 | 151 | 24 | $77K |
| Doxycycline Monohydrate Generic | 100 | 100 | 82 | $766 |
| Ventolin Hfa Albuterol Sulfate | 98 | 100 | 25 | $5,726 |
| Zolpidem Tartrate Er Zolpidem Tartrate | 72 | 76 | 11 | $3,475 |
Brand drugs: 2,781 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid An H Pham $6,587 ($6,587 in general payments such as food, travel and fees) from 31 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $1,322.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 51 | $1,322 |
| Verona Pharma, Inc. VRNA | 47 | $720 |
| Genzyme Corporation SNY | 25 | $710 |
| GlaxoSmithKline, LLC. GSK | 23 | $396 |
| Harmony Biosciences LLC HRMY | 8 | $334 |
| Mallinckrodt Hospital Products Inc. | 14 | $308 |
| Insmed, Inc. INSM | 9 | $299 |
| Actelion Pharmaceuticals US, Inc. JNJ | 18 | $295 |
| Avadel CNS Pharmaceuticals, LLC | 9 | $291 |
| Regeneron Healthcare Solutions, Inc. REGN | 12 | $230 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.